[go: up one dir, main page]

GR1004204B - Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses - Google Patents

Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses

Info

Publication number
GR1004204B
GR1004204B GR990100331A GR990100331A GR1004204B GR 1004204 B GR1004204 B GR 1004204B GR 990100331 A GR990100331 A GR 990100331A GR 990100331 A GR990100331 A GR 990100331A GR 1004204 B GR1004204 B GR 1004204B
Authority
GR
Greece
Prior art keywords
genetic
diagnostic
amniotic
human cells
future therapeutic
Prior art date
Application number
GR990100331A
Other languages
Greek (el)
Other versions
GR990100331A (en
Inventor
Original Assignee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by filed Critical
Publication of GR990100331A publication Critical patent/GR990100331A/en
Publication of GR1004204B publication Critical patent/GR1004204B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

his invenion belongs to the field of biotechnology, cryobiology and human therapeutics. Object of the invention are a) amniotic cells originating from amniotic fluid that surrounds the embryo in its early development stages, c) every biological material which will be created directly of idirectly from the above amniotic cells, as well as every biological product or byproduct which will be the outcome of the use of the said cryopreserved amniotic cells, through their reproduction on multiplication under the same or any other modified form and which will possess the same genetic properties and applications.
GR990100331A 1999-09-29 1999-09-29 Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses GR1004204B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR99100331 1999-09-29

Publications (2)

Publication Number Publication Date
GR990100331A GR990100331A (en) 2001-05-31
GR1004204B true GR1004204B (en) 2003-09-05

Family

ID=10943929

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990100331A GR1004204B (en) 1999-09-29 1999-09-29 Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses

Country Status (3)

Country Link
AU (1) AU7437900A (en)
GR (1) GR1004204B (en)
WO (1) WO2001023532A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265281A1 (en) * 2003-04-07 2004-12-30 Denis Rodgerson System capable of treating and defining various diseases using stem cells
US20050042595A1 (en) 2003-08-14 2005-02-24 Martin Haas Banking of multipotent amniotic fetal stem cells
JP4777908B2 (en) 2004-02-02 2011-09-21 コア・ダイナミクス・リミテッド Biological materials and methods and solutions for storage of biological materials
US8196416B2 (en) 2004-02-02 2012-06-12 Core Dynamics Limited Device for directional cooling of biological matter
WO2005120591A1 (en) 2004-06-07 2005-12-22 I.M.T. Interface Multigrad Technology Ltd. Method for sterilization of biological preparations
EP1778007A1 (en) 2004-08-12 2007-05-02 I.M.T. Interface Multigrad Technology Ltd. Method and apparatus for freezing or thawing of a biological material
US8198085B2 (en) 2005-08-03 2012-06-12 Core Dynamics Limited Somatic cells for use in cell therapy
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
CA2986702C (en) 2015-05-21 2023-04-04 David Wang Modified demineralized cortical bone fibers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8803697D0 (en) * 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
US5405751A (en) * 1994-01-12 1995-04-11 Schering Corporation Prenatal diagnosis by cytokine-induced proliferation of fetal T-cells
DE69726054D1 (en) * 1996-01-23 2003-12-18 Srl Inc CELLS FOR THE TREATMENT OF DEMENTIA
US5897987A (en) * 1996-03-25 1999-04-27 Advanced Reproduction Technologies, Inc. Use of arabinogalactan in cell cryopreservation media
WO2000073421A2 (en) * 1999-06-02 2000-12-07 Lifebank Services, L.L.C. Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells

Also Published As

Publication number Publication date
GR990100331A (en) 2001-05-31
AU7437900A (en) 2001-04-30
WO2001023532A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
UA101301C2 (en) Isolated il-23pl9 antibody and use thereof
Marijt et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1-or HA-2-specific T cells can induce complete remissions of relapsed leukemia
EP1784639A4 (en) METHODS FOR PREPARING LYOPHILIZED PLAQUETTES, COMPOSITIONS CONTAINING THE LYOPHILIZED PLAQUETTES, AND METHODS OF USE THEREOF
MA68598B1 (en) METHODS FOR PRODUCING TUMOR-INFILTRATING LYMPHOCYTES AND THEIR USES IN IMMUNOTHERAPY
DK1053256T3 (en) Antibodies to Death Receptor 4 (DR4) and Applications thereof
GR1004204B (en) Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses
MY147516A (en) Compositions and method of vascular injury repair cross-reference to related applications
HK1086750A1 (en) Pharmaceutical composition for inducing an immune response in a human or animal
ATE492651T1 (en) MOESIN, CAVEOLIN 1 AND YES-ASSOCIATED PROTEIN 1 AS PREDICTIVE MARKERS OF RESPONSE TO DASATINIB IN BREAST CANCER
CA2530416A1 (en) Postpartum cells derived from placental tissue, and methods of making and using the same
HUP0302523A2 (en) Genes encoding novel proteins with pesticidal activity against coleopterans
PL1639013T3 (en) Pan-kir2dl NK-receptor antibodies and their use in diagnostic and therapy
ATE280226T1 (en) GENETIC MARKERS FOR BREAST AND Ovarian CANCER
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
WO2007070640A3 (en) Use of roma for characterizing genomic rearrangements
PL356846A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
EP0769968A4 (en) RETROVIRAL VECTORS PRODUCED BY HUMAN SERUM LYSE RESISTANT PRODUCT CELL LINES
FR2586428B1 (en) POLYPEPTIDES AND ANTIBODIES, CHARACTERISTICS OF PAPILLOMAVIRUS AND THEIR APPLICATIONS TO IN VITRO DIAGNOSIS, PREVENTION AND / OR CONTROL OF PAPILLOMAVIRUS INFECTIONS
WO2007067905A3 (en) THERAPEUTIC USE FOR α1 PROTEINASE INHIBITOR IN HEMATOPOIESIS
WO2004046332A3 (en) Amplified genes involved in cancer
WO2003100000A3 (en) Amplification and overexpression of oncogenes
NO20010940D0 (en) TAN-1057 derivatives
WO2003076610A3 (en) Variants of human kallikrein-2 and kallikrein-3 and uses thereof
FR2789588B1 (en) USE OF AN OMPA ENTEROBACTERIA PROTEIN ASSOCIATED WITH AN ANTIGEN IN A PHARMACEUTICAL COMPOSITION FOR GENERATING OR INCREASING ANTIVIRAL, PEST CONTROL OR ANTITUMOR CYTOTOXIC RESPONSE
ATE311456T1 (en) NUCLEIC ACID MOLECULES ENCODING PROTEINS THAT MEDIATE THE ADHESION OF NEISSERIA CELLS TO HUMAN CELLS

Legal Events

Date Code Title Description
PG Patent granted
ML Lapse due to non-payment of fees

Effective date: 20120403